Zantac Settlement Payout 2025: What Claimants Should Know
The Zantac litigation continues to receive national attention as thousands of individuals pursue claims alleging that the heartburn medication caused serious health complications. Many plaintiffs claim that prolonged use of Zantac exposed them to harmful levels of NDMA, a chemical linked to cancer risks. As legal proceedings continue, interest surrounding the Zantac settlement payout 2025 has increased significantly. Individuals diagnosed with certain cancers after using Zantac are seeking guidance from experienced lawyers for Zantac lawsuit claims to determine whether they qualify for compensation. People for Law helps Florida residents navigate complex mass tort litigation involving dangerous pharmaceutical products. Why the Zantac Lawsuits Were Filed Zantac lawsuits allege that the medication’s active ingredient, ranitidine, could break down into NDMA under certain conditions. NDMA is classified as a probable human carcinogen, leading to concerns about long-term health risks...